Titan Medical announces that its global intellectual property portfolio has increased to 30 issued patents and 75 pending applications through the recent granting and filing of patent applications directed at aspects of its innovative robotic surgery program. Included in the recent patent grants is the Company’s first patent in China titled “Articulated Tool Positioner and System Employing Same,” for which the Company announced a notice of allowance in December 2018. The recently granted Chinese patent describes the smooth and continuously curved articulation of a robotic instrument to position and orient an end-effector in multiple degrees of freedom. The continuous curve architecture was designed to provide several advantages, including facilitating a central lumen that extends through the instrument to enable an independent roll of the end-effector, and providing for a multitude of end-effectors and advanced tools. Corresponding patents have been granted in Europe, Canada and Japan, and further applications are pending in several countries including the U.S.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.